检索结果 - Weifan Ye

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma

    Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma 由 Ajay K. Gopal, Michelle A. Fanale, Craig H. Moskowitz, Andrei R. Shustov, Siddhartha Mitra, Weifan Ye, Anas Younes, Alison J. Moskowitz

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: